Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Template:SUIT-006 NADH mt D084"

From Bioblast
(Created page with "{| class="wikitable" border="1" {{Template:Chemicals header}} |- | 1PGM | {{Template:Pyruvate}}, {{Template:Glutamate}}, and {{Template:Malate}} | |- | 2D | {{Template:ADP}}...")
 
 
(13 intermediate revisions by 2 users not shown)
Line 1: Line 1:
[[Image:SUIT-MitoFit.png|right|190px|link=http://www.bioblast.at/index.php/MitoPedia:_SUIT |MitoPedia: SUIT]]
== Steps and respiratory states ==
[[File:mt;1PGM;2D;3(Omy);4U;5Anox;6Myx;7Reox.png|300px]]
{| class="wikitable" border="1"
{| class="wikitable" border="1"
{{Template:Chemicals header}}
{{Template:SUIT header}}
 
|-
| mt
| [[REN]]
|
|
| mt
 
*{{Template:SUIT REN NADH}}


|-
|-
| 1PGM
| 1PGM
| {{Template:Pyruvate}}, {{Template:Glutamate}}, and {{Template:Malate}}
| [[PGM]]<sub>[[LEAK respiration|''L''(n)]]</sub> 
|
| [[N]]
| CI
| 1PGM
 
*{{Template:SUIT N}}
*{{Template:SUIT L(n)}}
 
|-
|-
| 2D
| 2D
| {{Template:ADP}}
| [[PGM]]<sub>''[[OXPHOS|P]]''</sub>
| [[N]]
| CI
| 1PGM;2D
 
*{{Template:SUIT N}}
*{{Template:SUIT OXPHOS}}
 
|-
| (3Omy)
| [[PGM]]<sub>[[LEAK respiration|''L''(Omy)]]</sub>
| [[N]]
| CI
| 1PGM;2D;(3Omy)
 
* Omy addition is skipped in SUIT-006 NADH mt D084
*{{Template:SUIT N}}
*{{Template:SUIT L(Omy)}}
 
|-
| 4U
| [[PGM]]<sub>''[[E]]''</sub>
| [[N]]
| CI
| 1PGM;2D;(3Omy);4U
 
*{{Template:SUIT N}}
*{{Template:SUIT U*}}
 
|-
| 5Anox
|  
|  
| [[N]]
| CI
| 1PGM;2D;(3Omy);4U;5Anox
*{{Template:SUIT Anoxia NADH}}
|-
|-
| 3U
| 6Myx
| {{Template:SF6847}}
|  
|
| [[N]]
| CI
| 1PGM;2D;(3Omy);4U;5Anox;6Myx
 
*{{Template:SUIT Myx}}
 
|-
|-
| 4Myx
| 7Reox
| {{Template:Myxothiazol}}
| [[ROX]]
|  
|  
| 1PGM;2D;(3Omy);4U;5Anox;6Myx;7Reox
*{{Template:SUIT Reox}}
|}
|}
{{Keywords: SUIT protocols}}

Latest revision as of 12:01, 5 January 2024

MitoPedia: SUIT

Steps and respiratory states

Mt;1PGM;2D;3(Omy);4U;5Anox;6Myx;7Reox.png


Step State Pathway Q-junction Comment - Events (E) and Marks (M)
mt REN mt
  • Respiration in the REN state is due to the presence of residual endogenous substrates.
  • In the absence of endogenous substrates, mt can be used for calibration of fully oxidized NAD.
1PGM PGML(n) N CI 1PGM
2D PGMP N CI 1PGM;2D
(3Omy) PGML(Omy) N CI 1PGM;2D;(3Omy)
  • Omy addition is skipped in SUIT-006 NADH mt D084
  • NADH-linked substrates (type N-pathway to Q).
  • Non-phosphorylating resting state (LEAK state); LEAK-respiration, L(Omy), after blocking the ATP synthase with oligomycin.
4U PGME N CI 1PGM;2D;(3Omy);4U
5Anox N CI 1PGM;2D;(3Omy);4U;5Anox
  • Anoxia, after the biological sample has consumed the O2 in the O2k-chamber, is used to detect the fully reduced NAD for calculation of the NAD redox states.
6Myx N CI 1PGM;2D;(3Omy);4U;5Anox;6Myx
  • The addition of myxothiazol after anoxia is a crucial step to detect the fully reduced NAD for calculation of the NAD redox state. Myxothiazol can induce a further reduction of NAD under anoxia.
7Reox ROX 1PGM;2D;(3Omy);4U;5Anox;6Myx;7Reox
  • The reoxygenation by opening the chamber in the presence of Myx allows for Rox-correction of the O2 fluxes.


Questions.jpg


Click to expand or collaps